• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

IFN-γ 分泌间充质干细胞通过 TRAIL 通路在体内发挥抗肿瘤作用。

IFN-γ-secreting-mesenchymal stem cells exert an antitumor effect in vivo via the TRAIL pathway.

机构信息

Department of Gynecology and Obstetrics, First Affiliated Hospital, School of Medicine, Xi'an Jiaotong University, Xi'an 710061, China.

Kingmed College of Laboratory Medicine, Guangzhou Medical University, Guangzhou 510182, China.

出版信息

J Immunol Res. 2014;2014:318098. doi: 10.1155/2014/318098. Epub 2014 May 26.

DOI:10.1155/2014/318098
PMID:24971369
原文链接:https://pmc.ncbi.nlm.nih.gov/articles/PMC4058226/
Abstract

Mesenchymal stem cells (MSCs) can exhibit either prooncogenic or antitumor properties depending on the context. Based on our previous study, we hypothesized that MSCs engineered to deliver IFN-γ would kill cancer cells through persistent activation of the TRAIL pathway. Human bone-marrow (BM-) derived MSCs were isolated, amplified, and transduced with a lentiviral vector encoding the IFN-γ gene under the control of the EF1α promoter. The IFN-γ-modified MSCs effectively secreted functional IFN-γ, which led to long-term expression of TRAIL. More importantly, the IFN-γ-modified MSCs selectively induced apoptosis in lung tumor cells through caspase-3 activation within the target cells. The percentage of activated-caspase-3-positive tumor cells in IFN-γ-modified MSCs cocultures was significantly higher than in control MSCs cocultures. Treatment with anti-TRAIL antibody dramatically suppressed the caspase-3 activation observed in H460 cells. After injection into nude mice, the IFN-γ-modified MSCs inhibited the growth and progression of lung carcinoma compared with control cells. Collectively, our results provide a new strategy for tumor therapy that utilizes IFN-γ-modified MSCs.

摘要

间充质干细胞(MSCs)的表现可以是致癌的或抗肿瘤的,这取决于具体情况。基于我们之前的研究,我们假设通过持续激活 TRAIL 途径来传递 IFN-γ 的工程 MSC 将通过杀死癌细胞。从人骨髓(BM)中分离、扩增和转导了一种慢病毒载体,该载体在 EF1α 启动子的控制下编码 IFN-γ 基因。IFN-γ 修饰的 MSC 有效地分泌了功能性 IFN-γ,导致 TRAIL 的长期表达。更重要的是,IFN-γ 修饰的 MSC 通过靶细胞内 caspase-3 的激活选择性地诱导肺癌细胞凋亡。IFN-γ 修饰的 MSC 共培养物中活化 caspase-3 阳性肿瘤细胞的百分比明显高于对照 MSC 共培养物。用抗 TRAIL 抗体处理可显著抑制 H460 细胞中观察到的 caspase-3 激活。IFN-γ 修饰的 MSC 注射到裸鼠后,与对照细胞相比,抑制了肺癌的生长和进展。总的来说,我们的结果为利用 IFN-γ 修饰的 MSC 进行肿瘤治疗提供了一种新策略。

https://cdn.ncbi.nlm.nih.gov/pmc/blobs/3771/4058226/f35ff85eba31/JIR2014-318098.005.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/3771/4058226/2998e337a1f7/JIR2014-318098.001.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/3771/4058226/e98b1a42748f/JIR2014-318098.002.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/3771/4058226/66c7935d158a/JIR2014-318098.003.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/3771/4058226/5a02775864d6/JIR2014-318098.004.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/3771/4058226/f35ff85eba31/JIR2014-318098.005.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/3771/4058226/2998e337a1f7/JIR2014-318098.001.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/3771/4058226/e98b1a42748f/JIR2014-318098.002.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/3771/4058226/66c7935d158a/JIR2014-318098.003.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/3771/4058226/5a02775864d6/JIR2014-318098.004.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/3771/4058226/f35ff85eba31/JIR2014-318098.005.jpg

相似文献

1
IFN-γ-secreting-mesenchymal stem cells exert an antitumor effect in vivo via the TRAIL pathway.IFN-γ 分泌间充质干细胞通过 TRAIL 通路在体内发挥抗肿瘤作用。
J Immunol Res. 2014;2014:318098. doi: 10.1155/2014/318098. Epub 2014 May 26.
2
IFN-γ-primed human bone marrow mesenchymal stem cells induce tumor cell apoptosis in vitro via tumor necrosis factor-related apoptosis-inducing ligand.IFN-γ- 预处理的人骨髓间充质干细胞通过肿瘤坏死因子相关凋亡诱导配体诱导肿瘤细胞凋亡。
Int J Biochem Cell Biol. 2012 Aug;44(8):1305-14. doi: 10.1016/j.biocel.2012.04.015. Epub 2012 Apr 24.
3
TRAIL-expressing gingival-derived mesenchymal stem cells inhibit tumorigenesis of tongue squamous cell carcinoma.表达肿瘤坏死因子相关凋亡诱导配体的牙龈间充质干细胞抑制舌鳞状细胞癌的肿瘤发生。
J Dent Res. 2015 Jan;94(1):219-28. doi: 10.1177/0022034514557815. Epub 2014 Nov 12.
4
TRAIL-overexpressing Adipose Tissue-derived Mesenchymal Stem Cells Efficiently Inhibit Tumor Growth in an H460 Xenograft Model.过表达 TRAIL 的脂肪组织来源间充质干细胞在 H460 异种移植模型中有效抑制肿瘤生长。
Cancer Genomics Proteomics. 2021 Jul-Aug;18(4):569-578. doi: 10.21873/cgp.20281.
5
Apoptin-modified human mesenchymal stem cells inhibit growth of lung carcinoma in nude mice.凋亡素修饰的人间充质干细胞抑制裸鼠肺癌生长。
Mol Med Rep. 2015 Jul;12(1):1023-9. doi: 10.3892/mmr.2015.3501. Epub 2015 Mar 17.
6
Irradiation enhances the tumor tropism and therapeutic potential of tumor necrosis factor-related apoptosis-inducing ligand-secreting human umbilical cord blood-derived mesenchymal stem cells in glioma therapy.辐照增强了分泌肿瘤坏死因子相关凋亡诱导配体的人脐带来源间充质干细胞在胶质瘤治疗中的肿瘤趋向性和治疗潜力。
Stem Cells. 2010 Dec;28(12):2217-28. doi: 10.1002/stem.543.
7
Antitumor effects of TRAIL-expressing mesenchymal stromal cells in a mouse xenograft model of human mesothelioma.TRAIL 表达间充质基质细胞在人胸膜间皮瘤小鼠异种移植模型中的抗肿瘤作用。
Cancer Gene Ther. 2015 Jan;22(1):44-54. doi: 10.1038/cgt.2014.68. Epub 2014 Dec 19.
8
Adipose tissue-derived mesenchymal stem cells cultured at high density express IFN-β and TRAIL and suppress the growth of H460 human lung cancer cells.高密度培养的脂肪组织来源间充质干细胞表达 IFN-β 和 TRAIL,并抑制 H460 人肺癌细胞的生长。
Cancer Lett. 2019 Jan;440-441:202-210. doi: 10.1016/j.canlet.2018.10.017. Epub 2018 Oct 26.
9
Gene therapy using TRAIL-secreting human umbilical cord blood-derived mesenchymal stem cells against intracranial glioma.使用分泌肿瘤坏死因子相关凋亡诱导配体(TRAIL)的人脐带血间充质干细胞进行基因治疗以对抗颅内胶质瘤。
Cancer Res. 2008 Dec 1;68(23):9614-23. doi: 10.1158/0008-5472.CAN-08-0451.
10
Dual-targeted antitumor effects against brainstem glioma by intravenous delivery of tumor necrosis factor-related, apoptosis-inducing, ligand-engineered human mesenchymal stem cells.通过静脉注射肿瘤坏死因子相关的凋亡诱导配体工程化人间充质干细胞对脑干胶质瘤产生双靶点抗肿瘤作用。
Neurosurgery. 2009 Sep;65(3):610-24; discussion 624. doi: 10.1227/01.NEU.0000350227.61132.A7.

引用本文的文献

1
Engineered Mesenchymal Stem Cells as Treatment for Cancers: Opportunities, Clinical Applications and Challenges.工程化间充质干细胞用于癌症治疗:机遇、临床应用与挑战
Malays J Med Sci. 2024 Oct;31(5):56-82. doi: 10.21315/mjms2024.31.5.5. Epub 2024 Oct 8.
2
Applications of Modified Mesenchymal Stem Cells as Targeted Systems against Tumor Cells.改性间充质干细胞作为靶向系统对抗肿瘤细胞的应用。
Int J Mol Sci. 2024 Jul 16;25(14):7791. doi: 10.3390/ijms25147791.
3
Biology and Therapeutic Properties of Mesenchymal Stem Cells in Leukemia.

本文引用的文献

1
Ex vivo expansion of hematopoietic stem- and progenitor cells from cord blood in coculture with mesenchymal stroma cells from amnion, chorion, Wharton's jelly, amniotic fluid, cord blood, and bone marrow.在体外与羊膜、绒毛膜、华通氏胶、羊水、脐血和骨髓来源的间充质基质细胞共培养,从脐血中扩增造血干/祖细胞。
Tissue Eng Part A. 2013 Dec;19(23-24):2577-85. doi: 10.1089/ten.tea.2013.0073.
2
Interferon-α-secreting mesenchymal stem cells exert potent antitumor effect in vivo.分泌α干扰素的间充质干细胞在体内发挥强大的抗肿瘤作用。
Oncogene. 2014 Oct 16;33(42):5047-52. doi: 10.1038/onc.2013.458. Epub 2013 Nov 4.
3
Infiltrating bone marrow mesenchymal stem cells increase prostate cancer stem cell population and metastatic ability via secreting cytokines to suppress androgen receptor signaling.
间充质干细胞在白血病中的生物学特性与治疗特性
Int J Mol Sci. 2024 Feb 21;25(5):2527. doi: 10.3390/ijms25052527.
4
Anti-triple-negative breast cancer metastasis efficacy and molecular mechanism of the STING agonist for innate immune pathway.激动先天免疫通路的 STING 激动剂的抗三阴性乳腺癌转移功效和分子机制。
Ann Med. 2023 Dec;55(1):2210845. doi: 10.1080/07853890.2023.2210845.
5
The Role of Mesenchymal Stem Cells and Exosomes in Tumor Development and Targeted Antitumor Therapies.间充质干细胞和外泌体在肿瘤发展及靶向抗肿瘤治疗中的作用
Stem Cells Int. 2023 Feb 14;2023:7059289. doi: 10.1155/2023/7059289. eCollection 2023.
6
The Effects of Mesenchymal Stem Cells on Oral Cancer and Possible Therapy Regime.间充质干细胞对口腔癌的影响及可能的治疗方案
Front Genet. 2022 Jun 30;13:949770. doi: 10.3389/fgene.2022.949770. eCollection 2022.
7
Possible Treatment Approaches of Sulfur Mustard-Induced Lung Disorders, Experimental and Clinical Evidence, an Updated Review.硫芥诱导的肺部疾病的可能治疗方法:实验与临床证据,最新综述
Front Med (Lausanne). 2022 Apr 29;9:791914. doi: 10.3389/fmed.2022.791914. eCollection 2022.
8
Modified mesenchymal stem cells in cancer therapy: A smart weapon requiring upgrades for wider clinical applications.癌症治疗中的修饰间充质干细胞:一种需要升级以实现更广泛临床应用的智能武器。
World J Stem Cells. 2022 Jan 26;14(1):54-75. doi: 10.4252/wjsc.v14.i1.54.
9
An overview of mesenchymal stem cells and their potential therapeutic benefits in cancer therapy.间充质干细胞概述及其在癌症治疗中的潜在治疗益处。
Oncol Lett. 2021 Nov;22(5):785. doi: 10.3892/ol.2021.13046. Epub 2021 Sep 14.
10
Mesenchymal Stem/Stromal Cells as a Vehicle for Cytokine Delivery: An Emerging Approach for Tumor Immunotherapy.间充质干/基质细胞作为细胞因子递送载体:肿瘤免疫治疗的一种新兴方法。
Front Med (Lausanne). 2021 Aug 27;8:721174. doi: 10.3389/fmed.2021.721174. eCollection 2021.
浸润骨髓间充质干细胞通过分泌细胞因子抑制雄激素受体信号来增加前列腺癌干细胞群体和转移能力。
Oncogene. 2014 May 22;33(21):2768-78. doi: 10.1038/onc.2013.233. Epub 2013 Jun 24.
4
Colon cancer mesenchymal stem cells modulate the tumorigenicity of colon cancer through interleukin 6.结直肠癌间质干细胞通过白细胞介素 6 调节结直肠癌的肿瘤发生。
Exp Cell Res. 2013 Aug 15;319(14):2216-29. doi: 10.1016/j.yexcr.2013.06.003. Epub 2013 Jun 7.
5
Mesenchymal stem cell 1 (MSC1)-based therapy attenuates tumor growth whereas MSC2-treatment promotes tumor growth and metastasis.基于间充质干细胞 1(MSC1)的治疗可减轻肿瘤生长,而 MSC2 治疗则促进肿瘤生长和转移。
PLoS One. 2012;7(9):e45590. doi: 10.1371/journal.pone.0045590. Epub 2012 Sep 20.
6
TRAIL-engineered pancreas-derived mesenchymal stem cells: characterization and cytotoxic effects on pancreatic cancer cells.TRAIL 工程化胰腺来源间充质干细胞:鉴定及其对胰腺癌细胞的细胞毒性作用。
Cancer Gene Ther. 2012 Sep;19(9):652-8. doi: 10.1038/cgt.2012.46. Epub 2012 Jul 6.
7
IFN-γ-primed human bone marrow mesenchymal stem cells induce tumor cell apoptosis in vitro via tumor necrosis factor-related apoptosis-inducing ligand.IFN-γ- 预处理的人骨髓间充质干细胞通过肿瘤坏死因子相关凋亡诱导配体诱导肿瘤细胞凋亡。
Int J Biochem Cell Biol. 2012 Aug;44(8):1305-14. doi: 10.1016/j.biocel.2012.04.015. Epub 2012 Apr 24.
8
Origins of the tumor microenvironment: quantitative assessment of adipose-derived and bone marrow-derived stroma.肿瘤微环境的起源:脂肪组织和骨髓来源的基质的定量评估。
PLoS One. 2012;7(2):e30563. doi: 10.1371/journal.pone.0030563. Epub 2012 Feb 20.
9
Human ovarian carcinoma–associated mesenchymal stem cells regulate cancer stem cells and tumorigenesis via altered BMP production.人卵巢癌相关间充质干细胞通过改变 BMP 产生调节癌症干细胞和肿瘤发生。
J Clin Invest. 2011 Aug;121(8):3206-19. doi: 10.1172/JCI45273.
10
A new mesenchymal stem cell (MSC) paradigm: polarization into a pro-inflammatory MSC1 or an Immunosuppressive MSC2 phenotype.一种新的间充质干细胞 (MSC) 范式:极化为促炎 MSC1 或免疫抑制 MSC2 表型。
PLoS One. 2010 Apr 26;5(4):e10088. doi: 10.1371/journal.pone.0010088.